Search Press releases Keywords From To 22 Apr 2003 UCB: First quarter Zyrtec sales in the US. Read More 1 Apr 2003 Data analysis shows Keppra® reduced partial seizures in nearly 80 percent of elderly patients in a community-based trial. Read More 14 Mar 2003 UCB Group : confirmation of an increase in ordinary profits of 7%. Read More 26 Feb 2003 Celltech Group PLC (CCH) - Offer for Oxford GlycoScience Read More 6 Feb 2003 The UCB Group in 2002: Preliminary Unaudited Profits. Record Ordinary Profits before Tax of € 494 million, an increase of 7% Read More 31 Jan 2003 UCB closes on its acquisition of Solutia's Resins, Additives and Adhesives businesses Read More Pagination First page Previous page Previous … Page 191 Page 192 Page 193 Page 194 Page 195 Page 196 Page 197 Current page 198 Page 199 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
